Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The Food and Drug Administration has approved Ozempic ® (semaglutide) to reduce the risk of sustained estimated glomerular ...

2. Girndt M, Trocchi P ... to kidney and cardiovascular outcomes for patients with non-dialysis chronic kidney disease stages 3–5: a network meta-analysis of randomised clinical trials.

Tea consumption offers protective effects on mortality among patients with chronic kidney disease, according to study findings.

People with kidney disease may be at higher risk of anxiety and depression. But taking care of your mental health can have a positive effect on your outlook with kidney disease. Chronic kidney ...

Medscape Medical News, December 02, 2024 Denosumab Raises Hypocalcemia Risk in Chronic Kidney Disease The risk for emergently treated hypocalcemia in individuals receiving denosumab peaked at 2 ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

More information: Zhilong Zhang et al, Association of Smoking with Chronic Kidney Disease Stages 3 to 5: A Mendelian Randomization Study, Health Data Science (2024). DOI: 10.34133/hds.0199 ...